Bruker (BRKR) 10-Q2019 Q1 Quarterly report

Filed: 8 May 19, 3:40pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: added, AFM, Beach, Billerica, billion, borrow, borrowing, classification, cleaning, collateralized, complemented, comprise, constant, Delray, dependent, depending, employment, environment, figure, Florida, framework, hybrid, implicit, inception, leader, lessee, lessor, LLC, loan, Mestrelab, noncancellable, North, notified, package, photomask, portray, post, prepayment, probe, proportion, Rave, recommend, redemption, rent, repair, residual, ROU, software, sought, technical, tied, treat, unique, unregistered, vehicle, world

Removed: acceptance, account, accounted, affecting, affiliated, allocating, allocation, Alternatively, analyze, analyzed, application, apply, assessment, behalf, behavior, billable, biopharmaceutical, Bulletin, call, clarify, Clarifying, Codification, collected, commonly, concentrated, connection, constitute, contraction, contractual, cooperate, core, criteria, cumulative, customized, deductible, defect, delay, demonstrate, depict, deposit, deterioration, determining, develop, disposed, distinct, duration, enactment, entitled, erosion, evaluated, evidence, existed, extended, factory, finalize, frequent, fulfillment, funding, handling, Hysitron, identifiable, identifying, impacted, implement, implementation, Improving, Incorporated, independent, influence, instability, installation, interpret, invested, investment, joint, key, law, leading, legislation, lower, macroeconomic, marketplace, mechanical, met, modest, modified, multiple, nanomechanical, nanoscale, necessitate, obtaining, parent, partner, passage, pay, permitted, political, portfolio, postretirement, preclinical, President, prevention, principle, producing, promised, protection, provisional, qualify, ratably, realizable, receiving, redeem, response, responsible, Retirement, retrospective, reverse, review, Rule, satisfied, satisfying, scope, screen, ship, shipment, shipping, showed, size, Slower, spending, standalone, strategic, subjecting, successful, surface, surrendered, taxation, territorial, testing, thermal, training, transitional, tribology, uncertainty, warranted, weaker, wide, worldwide, yield

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated BRKR transcripts

BRKR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Bruker Corporation (Company) on Form 10-Q for the three months ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (Report), each of the undersigned, Frank H. Laukien, President, Chief Executive Officer and Chairman of the Board of Directors of the Company, and Gerald N. Herman, Chief Financial Officer and Vice President of the Company, certifies, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

(1) The Report fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 8, 2019	By:	/s/ FRANK H. LAUKIEN, PH.D.
		Frank H. Laukien, Ph.D.
		President, Chief Executive Officer and Chairman
		(Principal Executive Officer)

Date: May 8, 2019	By:	/s/ GERALD N. HERMAN
		Gerald N. Herman
		Chief Financial Officer and Vice President
		(Principal Financial Officer and Principal Accounting Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.